| Preliminary Scientific Programme |
| SATURDAY | SUNDAY | MONDAY | TUESDAY | WEDNESDAY |
| Tuesday, 13 June 2006 |
08.30 – 10.15 Room: Hall B Chairperson: Phenotyping of allergy patients using antibodies
and cytokines Immune responses in children: Too much and
too little of allergen exposure Asthma, rhinitis and eczema: What can be learnt
from IgE and IgG antibodies? Advances with resolving the IgE antibody response
when prescribing ImmunoTherapy Room: Hall D Chairpersons: Occupational asthma as a model of the inception
and progression of asthma Similarities between IgE independent occupational
asthma and non-atopic asthma The relationship between bronchoconstriction,
airway hyperresponsiveness and airway inflammation in occupational and
non-occupational asthma Can asthma be prevented or cured by avoiding
exposure to the sensitising agent? Lessons from occupational asthma
7: Food Intolerance 8: The Different Faces of Histamine 9: What You Should Know about Allergy in Athletes 10. What can be behind chronic cough? 11. How early is Early Allergen Exposure? Room: Hall L Chairpersons: Indications, Contraindications, Side effects Practical aspects, Injection technique Cases and Discussion
Room: Hall M Chairpersons:
Room: Hall N Chairpersons: Introductory lecture: Diagnosis of insect venom
allergy: guidelines for clinical practice from the EAACI Interest Group
Room: Hall O Chairpersons: 10.30-12.15
Room: Hall F Chairpersons: The nose: Site for allergic inflammation and
control of disease Acute and chronic allergic inflammation in
the lung The skin: A window into systemic allergy? The gut: Site for sensitisation and tolerance
induction 12.15 – 13.30 Hall X & Y Posters 926 - 1623 and 1690 - 1713 in the Poster Exhibition will be discussed during the lunch hour. All delegates attending the Poster Exhibition will receive a sandwich lunch. 12.15 – 13.30 Room: Hall E1 Chairperson: Anthony Frew Paul O’Byrne, United Kingdom, Chairman of PhARF Scientific Committee,
will The Award Winner, Barbara Bohle, Austria will present her research “The impact of pollen-related food allergens on pollen allergy” Lunch will be served (estimated nr of participants 150) in connection to the Ceremony. 13.30 – 15.15 Room: Hall B Chairperson: 100 years of allergy – evolution and
revolution What do our patients deserve? Meeting the needs of patients with nasal allergy
- better drugs with better delivery Meeting patients’ needs – the next
major step in the evolution of allergic rhinitis therapy Questions and discussion Summary and close
Room: Hall F Chairperson: Asthma: a collection of different diseases? Cellular and molecular mechanisms of asthma Pharmacologic intervention to reduce the risk
of progression of asthma Non-pharmacologic approaches to reduce the
risk of progression to asthma Room: Hall D Chairpersons: Dendritic cells in the induction of peripheral
tolerance Mechanisms of mucosal tolerance Rapid generation and life span of human T
regulatory cells Regulation of allergen specific IgE, IgG and
IgA by human T regulatory cells Room: Hall G Chairpersons: Approaches towards engineered allergy vaccines Engineering vaccines for Parietaria allergy Allergen-derived B cell epitopes for allergy
vaccination Mechanisms underlying immunotherapy with genetically
modified allergens
Room: Hall H Chairpersons: Food challenges revisited, are they still useful? Sensitisation to aero-allergens and food allergy OAS in the North, anaphylaxis in the South Gastrointestinal food allergy in adults: The
challenge of diagnosis Room: Hall I Chairperson: Eosinophils: from allergy to host defense Eosinophils in asthma Gene expression in eosinophils Eosinophil esophagitis
Room: Hall K Chairpersons: The mucosal immune system Allergen presentation through the gut The role of intestinal microflora in allergy Celiac disease as autoimmune disease
Room: Hall C Chairpersons: New developments in autoimmunity Pemphigus vulgaris - paradigms of autoimmune
skin diseases Autoimmune mechanism in artherosclerosis Biologicals in the treatment of autoimmune
disease
Room: Hall N Chairpersons:
Room: Hall O Charipersons: Introductory lecture: Managing pediatric allergies
in the community 15.30 – 17.15 Room: Hall C Chairpersons: The clinicians view about threshold levels Detection and relevance of hidden allergens Clinical and individual importance of tresholds Scientific studies for exemption from food
labeling Room: Hall F Chairpersons: Requirement for treatment with immunotherapy Subcutaneous immunotherapy in adults: standards
for a quality practise Non-injective immunotherapy in adults: standards
for a quality practise Immunotherapy in pediatrics: standards for
a quality practise Room: Hall D Chairpersons: The relevance of inflammatory dendritic epidermal
cells (IDEC) T cells in delayed reactions Leukocytes in eczema Clinical lessons to be learned
Room: Hall E2 Chairpersons: Specific antibodies as predictive/prognostic
factors Serologic markers of occupational sensitisation
to chemicals Induced sputum in the evaluation of occupational
asthma Non-invasive markers from the airways: exhaled
gases and breath condensate Room: Hall G Chairpersons: Clinical value of basophil-based cellular tests:
opportunities and limitations IgG antibody testing in allergy, sense and
non-sense Advances of high-through put microchip technology
in allergy diagnosis The clinical relevance of componentresolved
diagnosis
Room: Hall H Chairperson: Microbes-friends or foes Modulation of immune responses by environmental
exposure to microbes: Animal models for asthma
Room: Hall B Chairpersons: The epidemiology of airway allergic diseases:
from rhinitis to asthma Do viruses play a role in rhinitis and asthma
exacerbations? Inflammation in the nose - inflammation in
the lung: where’s the link? Remodelling: similarities and differences between
occurrence in the nose and in the lungs Revising guidelines for “Early Diagnosis,
Early Treatment”, ARIA Update
Chairpersons: Pro: Hygiene and environment influences the
development of allergic diseases Con: Genetic polymorphisms are decisive in
the development of allergic diseases
Room: Hall N Chairpersons: Introductory lecture: The challenge of understanding
drug hypersensitivity pathogenic mechanisms 17.30 – 19.15 Room: Hall G Chairpersons: The impact of structural biology on allergen
classification Structure and cross-reactivity The structural biology of Bet v 1 homologous
allergens The structural biology of house dust mite
allergens
Room: Hall I Chairperson: Novel safety-optimised and low dose gene vaccines
for the treatment of Type I allergy Polynucleotides as danger signals Replicase-based DNA vaccines: immunogenicity
triggered via viral mimicry and apoptosis Gene gun immunisation for the treatment of
allergic disease - a paradox?
Room: Hall H Chairpersons: Allergen molecules Innate Immunity Basophils and mast cells Gene and protein microarrays in allergy Room: Hall K Chairpersons: Introductory lecture: Modeling asthma in mice
Room: Hall D Chairpersons:
Room: Hall L Chairpersons: Room: Hall M Chairpersons:
Room: Hall N Chairpersons: Introductory lecture: United Airways
Room: Hall O Chairpersons: Introductory lecture: Why do we have mast
cells? |